Kinvestor
News
Markets
Earnings
Insider
Portfolio
Pricing
Get Started
ASND
Ascendis Pharma A/S
Biotechnology
+ Watchlist
View SEC Filings
Overview
Financials
Earnings
Insider
Ownership
Filings
News
Ascendis Pharma A/S (ASND) Earnings
Last reported
April 29, 2026
EPS estimate
$0.28
EPS actual
—
Revenue est.
$278.9M
Revenue actual
—
Related:
ASND overview
·
ASND financials
·
ASND news